Sign in
Already have access? Choose your edition
Sign-in is edition-specific. New here? Start with the free brief instead of jumping straight into a trial.
Each edition has its own app, pricing, and coverage page. Use sign-in if you already have access; otherwise pick an edition and get the free daily + weekly brief first.
AI
Daily briefings on AI labs, policy, tooling, and community shifts.
Best for
- Model releases + evals
- Policy and safety narratives
- Tooling and platform shifts
Featured signalUnlocked today
Coverage discusses speculative scenarios for 2026; treat as market chatter and see linked sources.
Crypto
Daily briefings on markets, protocols, narratives, and risk events.
Best for
- Market structure + regulation
- Security and exploit narratives
- Protocol + dev ecosystem
Featured signalUnlocked today
German stock exchange operator Deutsche Börse has acquired a $200 million stake in Kraken's parent company, Payward, representing a 1.5% fully diluted owners...
CYBERSECURITY
Daily briefings on vulnerabilities, incidents, and threat intel.
Best for
- Vulns and advisories
- Incidents + exploit narratives
- Vendor and community disclosures
Featured signalUnlocked today
Anthropic's Mythos AI model, designed to identify and exploit cybersecurity vulnerabilities rapidly, is driving a new era of high-velocity cyberattacks.
ENERGY
Daily briefings on the energy transition: policy, grid, storage, and markets.
Best for
- Grid + reliability narratives
- Policy + first-party data
- Storage + transition supply chain
Featured signalUnlocked today
Suniva is investing $350 million to build a new 4.5 GW solar cell manufacturing facility in Laurens, South Carolina, expected to start operations in Q2 2027.
BIOTECH
Daily briefings on clinical, regulatory, and R&D updates from public sources.
Best for
- Clinical + regulatory narratives
- Research + preprints
- Funding + market updates
Featured signalUnlocked today
Travere Therapeutics has received FDA approval for Filspari to treat focal segmental glomerulosclerosis (FSGS), marking a significant milestone in addressing...